Anticoagulation for atrial fibrillation: Underutilization in a Brazilian tertiary outpatient clinic

Date
2004-11-01Author
Mesas, Cezar Eumann [UNIFESP]
Veloso, Henrique Horta [UNIFESP]
De Paola, Angelo Amato Vincenzo [UNIFESP]
Type
ResenhaISSN
0160-9289Is part of
Clinical CardiologyMetadata
Show full item recordAbstract
Despite a clear benefit of anticoagulation in patients with atrial fibrillation for the prevention of stroke, treatment rates are disappointingly low in clinical practice in the industrialized countries. This survey demonstrates similar rates in a Brazilian tertiary outpatient clinic, with only 55% of patients at high risk receiving dose-adjusted warfarin. Poor patient education and healthcare system limitations are considered important barriers. Strategies to improve treatment rates should target specific problems at each location.
Citation
Clinical Cardiology. Mahwah: Clinical Cardiology Publ Co, v. 27, n. 11, p. 592-+, 2004.Collections
- EPM - Artigos [17701]